Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04247334 · ClinicalTrials.gov registry record · NA

Inhibitory Control: Effects of Modulation

A NA study, sponsored by Butler Hospital.

Completed
Registry status
NA
Development phase
117
Enrollment target

NCT04247334 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 117 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04247334, a NA study, has completed, sponsored by Butler Hospital.

COMPLETED
Registry status
NA
Development phase
117 participants
Enrollment target

Study Summary

Inhibitory control is relevant to many clinical disorders, including substance abuse/dependence, obsessive-compulsive disorder, and attention-deficit hyperactivity disorder. This proposal is designed to assess brain networks related to response inhibition in healthy young adults, and use neuromodulation to change these networks and behavioral performance on a response inhibition task. Having an understanding of the brain mechanisms involved in response inhibition may enable us to improve pre-existing treatments for disorders with inhibitory control difficulties.

Interventions

  • DEVICE Transcranial direct current stimulation

Trial Details

FieldValue
Enrollment Target 117 participants
Start Date 2019-11-14
Est. Completion 2024-02-25
Phase NA

Sponsor

Butler Hospital

103 total trials

What the Registry Record Tells You About NCT04247334

The ClinicalTrials.gov registry entry for NCT04247334 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Transcranial direct current stimulation is the first listed.

NCT04247334 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04247334 about?

NCT04247334 is a clinical study titled "Inhibitory Control: Effects of Modulation". Inhibitory control is relevant to many clinical disorders, including substance abuse/dependence, obsessive-compulsive disorder, and attention-deficit hyperactivity disorder. This proposal is designed to assess brain networks related to response inhibition in healthy young adults, and use neuromodula...

What is the current status of trial NCT04247334?

This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2019-11-14. Estimated completion is 2024-02-25.

What interventions are being tested in trial NCT04247334?

The interventions under investigation include: Transcranial direct current stimulation (DEVICE).

Who is sponsoring clinical trial NCT04247334?

This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.